SAFETY OF USTEKINUMAB IN IBD: FINAL POOLED LONG-TERM SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 4 YEARS IN UC

被引：0
|
作者：
Sands, Bruce E.
Feagan, Brian G.
Ott, Elyssa
Gasink, Christopher
Marano, Colleen W.
Miao, Ye
Sandborn, William J.
Danese, Silvio
Abreu, Maria T.
Ghosh, Subrata
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1743
引用
收藏
页码：S889 / S889
页数：1
相关论文
共 50 条
  • [41] Long-term Efficacy and Safety of Siponimod in Patients with SPMS: EXPAND Extension Analysis Up to 5 Years
    Kappos, Ludwig
    Giovannoni, Gavin
    Gold, Ralf
    Fox, Robert J.
    Vermersch, Patrick
    Benedict, Ralph H. B.
    Bar-Or, Amit
    Rouyrre, Nicolas
    Meier, Daniela Piani
    Ritter, Shannon
    Kilaru, Ajay
    Dahlke, Frank
    Karlsson, Goeril
    Cree, Bruce A. C.
    NEUROLOGY, 2020, 94 (15)
  • [42] SECUKINUMAB'S LONG-TERM SAFETY REMAINS FAVORABLE UP TO 5 YEARS OF TREATMENT
    Griffiths, Christopher
    Blauvelt, A.
    Reich, K.
    Leonardi, C.
    Mehta, N.
    Tsai, T.
    You, R.
    Papanastasiou, P.
    Milutinovic, M.
    van de Kerkhof, P.
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 46 - 46
  • [43] ECCO 2023: New Long-term Data presented on the Efficacy of Ustekinumab in Ulcerative colitis and the Safety Profile of Ustekinumab in Crohn's Disease (CD) and Ulcerative colitis (UC)
    不详
    VISCERAL MEDICINE, 2023, 39 (3-4) : 98 - 98
  • [44] Long-Term Safety Of Ustekinumab: 5 Years Of Follow-Up From The Psoriasis Clinical Development Program Including Patients With Psoriatic Arthritis
    Papp, Kim
    Griffiths, Christopher E. M.
    Gordon, Kenneth B.
    Lebwohl, Mark
    Szapary, Philippe O.
    Wasfi, Yasmine
    Chan, Daphne
    Shen, Yaung-Kaung
    Ho, Vincent
    Ghislain, Pierre-Dominique
    Strober, Bruce
    Reich, Kristian
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S139 - S140
  • [45] Long-term safety of ustekinumab: 5 years of follow-up from the psoriasis clinical development program including patients with psoriatic arthritis
    Papp, Kim
    Reich, Kristian
    Lebwohl, Mark
    Wasfi, Yasmine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB174 - AB174
  • [46] LONG-TERM SAFETY OF USTEKINUMAB: 5 YEARS OF FOLLOW-UP FROM THE PSORIASIS CLINICAL DEVELOPMENT PROGRAM INCLUDING PATIENTS WITH PSORIATIC ARTHRITIS
    Papp, K.
    Griffiths, C.
    Gordon, K.
    Lebwohl, M.
    Szapary, P. O.
    Wasfi, Y.
    Chan, D.
    Shen, Y. K.
    Ho, V.
    Ghislain, P. D.
    Strober, B.
    Reich, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 680 - 680
  • [47] Long-term safety of ustekinumab: 5 years of follow-up from the psoriasis clinical development program including patients with psoriatic arthritis
    Papp, K.
    Griffiths, C. E. M.
    Gordon, K.
    Lebwohl, M.
    Szapary, P. O.
    Wasfi, Y.
    Chan, D.
    Shen, Y. K.
    Ho, V.
    Ghislain, P. D.
    Strober, B.
    Reich, K.
    SWISS MEDICAL WEEKLY, 2014, 144 : 5S - 5S
  • [48] LONG-TERM SAFETY ANALYSES FOR FINAL DISPOSAL
    STORCK, R
    KERNTECHNIK, 1987, 50 (01) : 50 - 52
  • [49] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
    Macdonell, R.
    Freedman, M. S.
    Ramio-Torrenta, L.
    Zaffaroni, M.
    De Seze, J.
    Ahn, S.
    Miller, A. E.
    Kallmann, B.
    Rog, D.
    Benamor, M.
    Truffinet, P.
    Chavin, J.
    Poole, E.
    Lebrun-Frenay, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 472 - 473
  • [50] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
    Freedman, Mark
    Inshasi, Jihad
    Ramio-Torrenta, Lluis
    Zaffaroni, Mauro
    de Seze, Jerome
    Ahn, Suk-won
    Macdonell, Richard
    Miller, Aaron
    Kallmann, Boris
    Rog, David
    Benamor, Myriam
    Truffinet, Philippe
    Chavin, Jeffrey
    Poole, Elizabeth
    Lebrun-Frenay, Christine
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 51 - 51
12345